Feb 15, 2023 Research News Lasting relief may be on the horizon for patients with atopic dermatitis LJI research collaboration with Kyowa Kirin Co., Ltd., points to a novel approach to treat the most common form of eczema Read More
Feb 14, 2023 Institute News New $17 million grant establishes LJI as global hub for immunology data curation and analysis NIAID support opens gateway to new research into human immune responses to viruses, the development of autoimmune diseases, and more Read More
Jan 30, 2023 Research News LJI scientists uncover the structure and function of Inmazeb, the first FDA-approved drug for Ebola virus infection LA JOLLA, CA—Scientists at La Jolla Institute for Immunology (LJI) have uncovered the structure and function of the first FDA-approved Read More